Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

Description

An investigational new drug contract development and manufacturing organization (CDMO) refers to a service provider that assists in the development and manufacturing of pharmaceutical compounds intended for clinical trial use under an Investigational New Drug (IND) application. These organizations operate in accordance with regulatory standards applicable to early-stage drug development, ensuring adherence to the guidelines necessary for progressing experimental therapies toward regulatory approval.

The primary products offered by investigational new drug CDMOs include small molecules and large molecules. Small molecules are low molecular weight compounds capable of easily penetrating cell membranes and interacting with intracellular targets to affect biological functions. These are developed into various formulations, such as solid, liquid, and injectable forms, and are supported by a range of services including preclinical studies, clinical trial material supply, regulatory support, and manufacturing services. The end users include pharmaceutical companies, biotechnology firms, academic and research institutions, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The investigational new drug contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides investigational new drug contract development and manufacturing organization (CDMO) market statistics, including investigational new drug contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a investigational new drug contract development and manufacturing organization (CDMO) market share, detailed investigational new drug contract development and manufacturing organization (CDMO) market segments, market trends and opportunities, and any further data you may need to thrive in the investigational new drug contract development and manufacturing organization (CDMO) industry. This investigational new drug contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The investigational new drug contract development and manufacturing organization (CDMO) market size has grown strongly in recent years. It will grow from $5.53 billion in 2024 to $5.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to the increasing demand for early-phase clinical trials, greater outsourcing by pharmaceutical companies, a rise in the development of biologics and complex molecules, enhanced regulatory support for expedited drug approvals, and a heightened emphasis on cost-efficiency and reducing time-to-market.

The investigational new drug contract development and manufacturing organization (CDMO) market size is expected to see strong growth in the next few years. It will grow to $7.67 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to the expanding emphasis on rare and orphan drug development, the increasing demand for integrated preclinical-to-clinical services, the rising complexity of biologics and gene therapies, growing investments in small molecule innovation, and the wider adoption of virtual pharma business models. Key trends expected during this period include advancements in integrated drug development platforms, the emergence of AI-driven clinical trial designs, innovations in personalized medicine manufacturing, progress in regulatory compliance technologies, and the development of flexible, modular manufacturing facilities.

The increase in clinical trials is expected to drive the growth of the investigational new drug contract development and manufacturing organization (CDMO) market moving forward. Clinical trials are carefully designed studies involving human participants to evaluate the safety and efficacy of medical treatments, procedures, or interventions under controlled conditions. The growth in clinical trials is primarily fueled by the rising demand for innovative treatments, as escalating rates of chronic and complex diseases push pharmaceutical and biotech companies to develop and test new therapies. Investigational new drug CDMOs support clinical trials by streamlining the development and manufacturing of trial-ready drug formulations, ensuring timely and compliant supply of investigational products for each phase of the study. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported a 4.3% increase in the annual number of industry-led clinical trials in the UK, rising from 394 in 2021 to 411 in 2022. Therefore, the rise in clinical trials is driving growth in the investigational new drug CDMO market.

Key players in the investigational new drug CDMO market are focusing on strategic partnerships to enhance development capabilities and accelerate clinical trial entry. Strategic partnerships are formal collaborations between two or more organizations that work together to achieve shared goals, leveraging each other's strengths, resources, or expertise while maintaining independent operations. For instance, in August 2023, Sartorius AG, a Germany-based life sciences company, partnered with Repligen Corporation, a US-based life sciences firm, to introduce an integrated system combining the BIOSTAT STR and XCell ATF technologies for upstream process intensification. This partnership aims to optimize biopharmaceutical production by improving efficiency and scalability. The collaboration highlights Sartorius' ongoing commitment to innovation in bioprocessing solutions and advancing the biomanufacturing industry.

In January 2024, Alcami Corporation, a US-based pharmaceutical contract development and manufacturing organization (CDMO), acquired Pacific Pharmaceutical Services for an undisclosed amount. This acquisition enables Alcami to expand its presence on the West Coast and strengthen its analytical testing and quality control capabilities. Pacific Pharmaceutical Services is a US-based company specializing in pharmaceutical testing and quality assurance services.

Major players in the investigational new drug contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., and Amaran Biotech Inc.

North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in investigational new drug contract development and manufacturing organization (CDMO) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the investigational new drug contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The investigational new drug contract development and manufacturing organization (CDMO) market includes revenues earned by entities through analytical method development, clinical trial material manufacturing, process development, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on investigational new drug contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for investigational new drug contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The investigational new drug contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Small Molecules; Large Molecules
2) By Formulation Type: Solid Formulations; Liquid Formulations; Injectable Formulations
3) By Service Type: Clinical Trial Material Supply; Regulatory Support Services; Manufacturing Services
4) By End-User: Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Small Molecules: Synthetic Small Molecules; Semi-synthetic Small Molecules; Peptide-based Small Molecules; Oligonucleotides
2) By Large Molecules: Monoclonal Antibodies (mAbs); Recombinant Proteins; Vaccines; Cell Therapy Products; Gene Therapy Products; RNA-based Therapeutics
Companies Mentioned: Thermo Fisher Scientific Inc.; Fresenius Kabi AG; Lonza Group Ltd.; Catalent Inc.; Samsung Biologics Co. Ltd.; Fareva SA; Recipharm AB; PCI Pharma Services; Vetter Pharma; Delpharm; Kindeva Drug Delivery LP; Ajinomoto Bio-Pharma Services; Cenexi SAS; Grand River Aseptic Manufacturing Inc.; INCOG BioPharma Services; Aurigene Pharmaceutical Services; Jubilant HollisterStier LLC; Symbiosis Pharmaceutical Services Ltd.; Afton Scientific Corp.; Amaran Biotech Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37032

1. Executive Summary

2. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

5.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis
5.4. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

6. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Segmentation

6.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Molecules
Large Molecules
6.2. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Formulations
Liquid Formulations
Injectable Formulations
6.3. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Preclinical Services
Clinical Trial Material Supply
Regulatory Support Services
Manufacturing Services
6.4. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Biotechnology Companies,
Academic And Research Institutes
Other End-Users
6.5. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Synthetic Small Molecules
Semi-synthetic Small Molecules
Peptide-based Small Molecules
Oligonucleotides
6.6. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Large Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies (mAbs)
Recombinant Proteins
Vaccines
Cell Therapy Products
Gene Therapy Products
RNA-based Therapeutics

7. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

7.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

8.1. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

9.1. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
9.2. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

10.1. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

11.1. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
11.2. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

12.1. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

13.1. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

14.1. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
14.2. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

15.1. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
15.2. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

16.1. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

17.1. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

18.1. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

19.1. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

20.1. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

21.1. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
21.2. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

22.1. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

23.1. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
23.2. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

24.1. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
24.2. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

25.1. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
25.2. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

26.1. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
26.2. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

27.1. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

28.1. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
28.2. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

29.1. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview
29.2. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

30.1. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
30.2. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Samsung Biologics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

31.1. Fareva SA
31.2. Recipharm AB
31.3. PCI Pharma Services
31.4. Vetter Pharma
31.5. Delpharm
31.6. Kindeva Drug Delivery LP
31.7. Ajinomoto Bio-Pharma Services
31.8. Cenexi SAS
31.9. Grand River Aseptic Manufacturing Inc.
31.10. INCOG BioPharma Services
31.11. Aurigene Pharmaceutical Services
31.12. Jubilant HollisterStier LLC
31.13. Symbiosis Pharmaceutical Services Ltd.
31.14. Afton Scientific Corp.
31.15. Amaran Biotech Inc.

32. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

34. Recent Developments In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

35. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

35.1 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities
35.2 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities
35.3 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer